Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-12-01 Sale |
2022-12-20 4:05 pm |
Oncocyte Corp | OCX | Ross Douglas T. Former CSO. |
150,000 | $0 | $0 | 298,545 (Direct) |
View |
| 2022-03-25 Purchase |
2022-03-28 8:00 pm |
Oncocyte Corp | OCX | Ross Douglas T. Chief Scientific Officer |
15,000 | $1.4 | $21,000 | 20,317 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-12-21 Option Award |
2022-12-22 6:57 pm |
N/A N/A |
Oncocyte Corp | OCX | Ross Douglas T. Former CSO |
213,797 | $0 | 234,114 (Direct) |
View |
| 2022-08-15 Option Award |
2022-08-17 8:24 pm |
N/A N/A |
Oncocyte Corp | OCX | Ross Douglas T. Chief Scientific Officer |
150,000 | $0 | 170,317 (Direct) |
View |
| 2022-03-15 Option Award |
2022-03-17 9:29 pm |
N/A 2032-03-15 |
Oncocyte Corp | OCX | Ross Douglas T. Chief Scientific Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2021-02-25 Option Award |
2021-03-01 4:23 pm |
N/A 2031-02-24 |
OncoCyte Corp | OCX | Ross Douglas T. Chief Medical Officer |
255,000 | $5.34 | 255,000 (Direct) |
View |
| 2020-12-11 Option Award |
2020-12-15 06:22 am |
N/A N/A |
OncoCyte Corp | OCX | Ross Douglas T. CMO |
5,317 | $0 | 5,317 (Direct) |
View |